Abstract:Cell-intrinsic reporters such as luciferase (LUC) and red fluorescent protein (RFP) have been commonly utilized in preclinical studies to image tumor growth and to monitor therapeutic responses. While extrinsic reporters that emit near infrared I (NIR-I: 650-950 nm) or near-infrared II (NIR-II: 1000 -1700 nm) optical signals have enabled minimization of tissue autofluorescence and light scattering, it has remained unclear as to whether their use has afforded more accurate tumor imaging in small animals. Here, we developed a novel optical imaging construct comprised of rare earth lanthanide nanoparticles coated with biodegradable diblock copolymers and doped with organic fluorophores, generating NIR-I and NIR-II emissive bands upon optical excitation. Simultaneous injection of multiple spectrally-unique nanoparticles into mice bearing tumor implants established via intraperitoneal dissemination of LUC+/ RFP+ OVCAR-8 ovarian cancer cells enabled direct comparisons of imaging with extrinsic vs. intrinsic reporters, NIR-II vs. NIR-I signals, as well as targeted vs. untargeted exogenous contrast agents in the same animal and over time. We discovered that in vivo optical imaging at NIR-II wavelengths facilitates more accurate detection of smaller and earlier tumor deposits, offering enhanced sensitivity, improved spatial contrast, and increased depths of tissue penetration as compared to imaging with visible or NIR-I fluorescent agents. Our work further highlights the hitherto underappreciated enhancements in tumor accumulation that may be achieved with intraperitoneal as opposed to intravenous administration of nanoparticles. Lastly, we found discrepancies in the fidelity of tumor uptake that could be obtained by utilizing small molecules for in vivo as opposed to in vitro targeting of nanoparticles to disseminated tumors. (C) 2017 Elsevier Ltd. All rights reserved.

Revealing the Fate of Transplanted Stem Cells In Vivo with a Novel Optical Imaging Strategy.

An NIR‐II Fluorescence/Dual Bioluminescence Multiplexed Imaging for in Vivo Visualizing the Location, Survival, and Differentiation of Transplanted Stem Cells

Noninvasive in-vivo tracing and imaging of transplanted stem cells for liver regeneration.

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

In Vivo Stem Cell Imaging

Assessing in Vitro Stem‐cell Function and Tracking Engraftment of Stem Cells in Ischaemic Hearts by Using Novel Irfp Gene Labelling

Near-infrared-persistent luminescence/bioluminescence imaging tracking of transplanted mesenchymal stem cells in pulmonary fibrosis

A Three-Dimensional Imaging Method for the Quantification and Localization of Dynamic Cell Tracking Posttransplantation

Recent Advances in Tracking the Transplanted Stem Cells Using Near-Infrared Fluorescent Nanoprobes: Turning from the First to the Second Near-Infrared Window

Tracking of Transplanted Human Mesenchymal Stem Cells in Living Mice Using Near‐Infrared Ag2S Quantum Dots

Differential Responses of Transplanted Stem Cells to Diseased Environment Unveiled by a Molecular NIR-II Cell Tracker

In Vivo Tracking of Individual Stem Cells Labeled with Nanowire Lasers Using Multimodality Imaging.

The Application of In Vivo Optical Imaging Technologies with Bioluminescence and Fluorescence on the Research of Stem Cell

Optical and MRI Multimodal Tracing of Stem Cells In Vivo

Utility of dual-modality bioluminescence and MRI in monitoring stem cell survival and impact on post myocardial infarct remodeling.

Labeling Stem Cells with A Near-Infrared Fluorescent Heptamethine Dye for Noninvasive Optical Tracking

Fluorescent Nanoparticles for Noninvasive Stem Cell Tracking in Regenerative Medicine

Multimodal Magnetic Resonance and Fluorescence Imaging of the Induced Pluripotent Stem Cell Transplantation in the Brain

Multimodality Molecular Imaging of Stem Cells Therapy for Stroke.

Stem Cell Tracking with Optically Active Nanoparticles.

Tracking Transplanted Cells in Live Animal Using Upconversion Fluorescent Nanoparticles